CHEMOTHERAPY FOLLOWED BY RADIOTHERAPY VERSUS RADIOTHERAPY ALONE IN LOCALLY ADVANCED CERVICAL-CANCER - A RANDOMIZED STUDY

被引:93
作者
KUMAR, L
KAUSHAL, R
NANDY, M
BISWAL, BM
KUMAR, S
KRIPLANI, A
SINGH, R
RATH, GK
KOCHUPILLAI, V
机构
[1] Department of Medical Oncology, Radiotherapy, Gynaecology, Obstetrics and Biostatistics, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences
关键词
D O I
10.1006/gyno.1994.1215
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Between August 1990 and January 1992, 184 patients with squamous cell carcinoma of the cervix, FIGO stage IIB-IVA, were randomized to receive either two cycles of bleomycin, ifosfamide-mesna, and cis-platinum (BIP) chemotherapy (CT) followed by radiotherapy (RT) (''CT-RT group,'' n = 94) or RT alone (RT group, n = 90). In the CT-PT group, of 89 evaluable patients, 64 responded: complete response (CR) 4 (4.5%) and partial response 60 (67.5%). Of the remaining 25 patients, 23 had stable disease and 2 progressed. Eighty of 89 patients completed RT as planned. Following RT 56 (70%) achieved CR, 19 (23.7%) had residual disease, and 5 (6.3%) had progressed. CT responders had a better response to RT: 83% (49/59) vs 33.3% (7/21), P < 0.01. The stage of disease, histologic grade, duration of symptoms, and history of smoking had no influence on the response to CT. Patients aged >45 years and those with Hb >10 g/dl had significantly better response. Nausea/vomiting, alopecia, grade I-II myelosuppression, diarrhea, and mucositis were the major side effects of CT. Two patients died of CT toxicity. In the RT group, 88 patients were evaluable: 61 (69.3%) patients achieved CR, 25 had residual disease, and 2 progressed. The side effects of RT were cystitis, proctitis, and local skin reaction. These were equally distributed between the two groups. There was no significant difference in overall and disease-free survival in the two groups. (C) 1994 Academic Press, Inc.
引用
收藏
页码:307 / 315
页数:9
相关论文
共 35 条
[1]  
CARDENAS J, 1991, P AN M AM SOC CLIN, V10, pA620
[2]  
CHAUVERGNE J, 1988, P AN M AM SOC CLIN, V7, pA524
[3]  
CLARK JR, 1988, SEMIN ONCOL, V15, P35
[4]  
COX DR, 1972, J R STAT SOC B, V34, P187
[5]   A PREOPERATIVE SINGLE COURSE OF HIGH-DOSE CISPLATIN AND BLEOMYCIN WITH GLUTATHIONE PROTECTION IN BULKY STAGE IB/II CARCINOMA OF THE CERVIX [J].
FONTANELLI, R ;
SPATTI, G ;
RASPAGLIESI, F ;
ZUNINO, F ;
DIRE, F .
ANNALS OF ONCOLOGY, 1992, 3 (02) :117-121
[6]  
GAMUCCI I, 1991, 3RD P INT C NEOADJ C, P66
[7]  
GOLDIN A, 1982, SEMIN ONCOL, V9, P14
[8]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[9]   EFFECT OF ANTISENSE C-RAF-1 ON TUMORIGENICITY AND RADIATION SENSITIVITY OF A HUMAN SQUAMOUS CARCINOMA [J].
KASID, U ;
PFEIFER, A ;
BRENNAN, T ;
BECKETT, M ;
WEICHSELBAUM, RR ;
DRITSCHILO, A ;
MARK, GE .
SCIENCE, 1989, 243 (4896) :1354-1356
[10]   2-YEAR SURVIVAL - PREOPERATIVE ADJUVANT CHEMOTHERAPY IN THE TREATMENT OF CERVICAL-CANCER STAGE-IB AND STAGE-II WITH BULKY TUMOR [J].
KIM, DS ;
MOON, H ;
KIM, KT ;
HWANG, YY ;
CHO, SH ;
KIM, SR .
GYNECOLOGIC ONCOLOGY, 1989, 33 (02) :225-230